Cargando…

Survival and Prognostic Factors of Ultra-Central Tumors Treated with Stereotactic Body Radiotherapy

SIMPLE SUMMARY: Stereotactic body radiotherapy for tumors directly touching or overlapping the trachea, proximal bronchial tree, or esophagus may be a high-risk clinical scenario. Some prognostic factors may be associated with better survival for ultra-central (UC) tumors. Indeed, the present study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salvestrini, Viola, Duijm, Marloes, Loi, Mauro, Nuyttens, Joost J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737655/ https://www.ncbi.nlm.nih.gov/pubmed/36497390 http://dx.doi.org/10.3390/cancers14235908

Ejemplares similares

Development and external validation of a nomogram to predict overall survival following stereotactic body radiotherapy for early-stage lung cancer
por: Baker, Sarah, et al.
Publicado: (2020)

Stereotactic Radiotherapy for Ultra-Central Lung Oligometastases in Non-Small-Cell Lung Cancer
por: Loi, Mauro, et al.
Publicado: (2020)

Local Reirradiation of Recurrent Non-small Cell Lung Carcinoma Resulting in Long Disease-free Survival, Although in the Presence of Osteonecrosis
por: Duijm, Marloes, et al.
Publicado: (2018)

Stereotactic body radiotherapy for moderately central and ultra-central oligometastatic disease: Initial outcomes
por: Cooke, Rosie, et al.
Publicado: (2020)

Re-Irradiation: Outcome, Cumulative Dose and Toxicity in Patients Retreated with Stereotactic Radiotherapy in the Abdominal or Pelvic Region
por: Abusaris, Huda, et al.
Publicado: (2012)

Single-Fraction Radiotherapy (SFRT) For Bone Metastases: Patient Selection And Perspectives
por: Loi, Mauro, et al.
Publicado: (2019)

Safety and Efficacy of Stereotactic Ablative Radiotherapy for Ultra-Central Lung Cancer
por: Wang, Bin, et al.
Publicado: (2022)

Progression of Pulmonary Function and Correlation with Survival Following Stereotactic Body Radiotherapy of Central and Ultracentral Lung Tumors
por: Regnery, Sebastian, et al.
Publicado: (2020)

Stereotactic body radiotherapy for central lung tumors, yes we can!
por: Korzets ceder, Yasmin, et al.
Publicado: (2018)

Study protocol and preliminary results from a mono-centric cohort within a trial testing stereotactic body radiotherapy and abiraterone (ARTO-NCT03449719)
por: Francolini, Giulio, et al.
Publicado: (2022)

Stereotactic ablative radiotherapy for ultra-central lung tumors: prioritize target coverage or organs at risk?
por: Murrell, Donna H., et al.
Publicado: (2018)

Stereotactic body radiotherapy (SBRT) for central and ultracentral node-negative lung tumors
por: Owen, Dawn, et al.
Publicado: (2020)

Hepatocellular Carcinoma in the COVID‐19 Era: Primetime for Stereotactic Body Radiotherapy and a Lesson for the Future?
por: Scorsetti, Marta, et al.
Publicado: (2020)

Thymic Carcinoma Treated by CyberKnife Stereotactic Body Radiotherapy
por: Harada, Yuko, et al.
Publicado: (2017)

Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases
por: Lischalk, Jonathan W., et al.
Publicado: (2016)

Developments in Stereotactic Body Radiotherapy
por: Haridass, Anoop
Publicado: (2018)

Stereotactic Body Radiotherapy for the Treatment of Renal Tumors()
por: Hanzly, Michael, et al.
Publicado: (2014)

A new prognostic score for predicting survival in patients treated with robotic stereotactic radiotherapy for brain metastases
por: Stankiewicz, Magdalena, et al.
Publicado: (2021)

Utility of Radiomics for Predicting Patient Survival in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis Treated With Stereotactic Body Radiotherapy
por: Wu, Kui, et al.
Publicado: (2020)

Endovascular coils as lung tumour markers in real-time tumour tracking stereotactic radiotherapy: preliminary results
por: Prévost, Jean-Briac G., et al.
Publicado: (2008)

The RSSearch™ Registry: patterns of care and outcomes research on patients treated with stereotactic radiosurgery and stereotactic body radiotherapy
por: Davis, Joanne N, et al.
Publicado: (2013)

Radiomics analysis at PET/CT contributes to prognosis of recurrence and survival in lung cancer treated with stereotactic body radiotherapy
por: Oikonomou, Anastasia, et al.
Publicado: (2018)

Stereotactic Body Radiotherapy for Prostate Cancer
por: Parikh, Neil R., et al.
Publicado: (2020)

Prognostic impact of biologically equivalent dose in stereotactic body radiotherapy for renal cancer
por: Tran, Kevin T., et al.
Publicado: (2023)

Lung metastases treated with stereotactic body radiotherapy: the RSSearch® patient Registry’s experience
por: Ricco, Anthony, et al.
Publicado: (2017)

Hepatocellular carcinoma with child Pugh-A Cirrhosis treated with stereotactic body radiotherapy
por: Hasan, Shaakir, et al.
Publicado: (2017)

Perfusion imaging of colorectal liver metastases treated with bevacizumab and stereotactic body radiotherapy
por: Detsky, Jay S., et al.
Publicado: (2018)

The impact of radiosensitivity on clinical outcomes of spinal metastases treated with stereotactic body radiotherapy
por: Guo, Lanlan, et al.
Publicado: (2023)

Stereotactic body radiotherapy for central lung tumors: Finding the balance between safety and efficacy in the “no fly” zone
por: Ahmed, Nissar, et al.
Publicado: (2018)

Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: Melanoma brain metastases prognostic score
por: Schaule, Jana, et al.
Publicado: (2020)

Integration between Novel Imaging Technologies and Modern Radiotherapy Techniques: How the Eye Drove the Chisel
por: Francolini, Giulio, et al.
Publicado: (2022)

Neutrophil-lymphocyte ratio as a prognostic factor for stereotactic body radiotherapy treatment of metastatic liver tumors
por: Xie, Xuyun, et al.
Publicado: (2020)

Stereotactic body radiotherapy for solitary spine metastasis
por: Lee, Sunyoung, et al.
Publicado: (2013)

A Survey of Stereotactic Body Radiotherapy in Korea
por: Bae, Sun Hyun, et al.
Publicado: (2015)

Stereotactic body radiotherapy in lung cancer: an update
por: Abreu, Carlos Eduardo Cintra Vita, et al.
Publicado: (2015)

Stereotactic Body Radiotherapy for Primary Prostate Cancer
por: Kothari, Gargi, et al.
Publicado: (2018)

Editorial: Stereotactic body radiotherapy for prostate cancer
por: Kishan, Amar U., et al.
Publicado: (2022)

Editorial: Stereotactic body radiotherapy for lung cancer
por: Liu, An, et al.
Publicado: (2023)

Survival and prognostic factors for patients with advanced hepatocellular carcinoma after stereotactic ablative radiotherapy
por: Lo, Cheng-Hsiang, et al.
Publicado: (2017)

Survival outcomes after stereotactic body radiotherapy for 79 Japanese patients with hepatocellular carcinoma
por: Yamashita, Hideomi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9u35ok77r7317g12pc47tbhcmr